J&J | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
AbbVie USD 3.32B 2.71B 2024-12
Abbott USD 49.06B 9.04B 2025-03
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Baxter International USD 6.96B 908M 2024-12
Bayer EUR 32.58B 537M 2025-03
Becton, Dickinson and Co. USD 25.24B 36M 2025-03
Biogen USD 16.98B 262.7M 2025-03
Boston Scientific USD 22.21B 443M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
CONMED USD 977.64M 14.96M 2025-03
Cooper Companies USD 8.13B 44.1M 2025-01
Dexcom USD 2.27B 164M 2025-03
Edwards Lifesciences USD 10B 452.8M 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Globus Medical USD 4.09B 89.26M 2025-03
Hologic USD 4.62B 154.6M 2025-03
Indivior -285000000 63M 2025-03
Insulet USD 1.33B 119.1M 2025-03
Integra LifeSciences USD 1.52B 21.14M 2025-03
Intuitive Surgical USD 17.21B 678.1M 2025-03
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merck USD 48.34B 2.02B 2025-03
Merit Medical Systems USD 1.43B 49.06M 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
Stryker USD 20.93B 296M 2025-03
Tandem Diabetes Care USD 155.29M 107.81M 2025-03
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12
Zoetis USD 4.66B 115M 2025-03



J&J Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.